In Consulting Services

PharmaNet Consulting offers a complete range of early- and later-stage consulting services to the pharmaceutical and biotechnology industries, As well as the life science investment community. Expert professionals with significant experience in product development and international Regulatory guidelines provide advice on topics covering the entire spectrum of development. Our professionals include former senior-level FDA officials And other international regulatory experts who are available to help address obstacles that may occur throughout product development.

Presentations

PharmaNet professionals frequently present significant papers at industry events,
and are published in leading trade journals. Please select any of the following PharmaNet professionals to read their papers and articles.

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting

 

Bengt Danielsson, MD, PhD

Vice President, PharmaNet Consulting


William M. Egan, PhD

Vice President, PharmaNet Consulting

 

Jeffrey J. Freitag, MD, FACP

Senior Vice President, PharmaNet Consulting


Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting

 

Gregory M. Hockel, MBA, PhD

Senior Vice President, Regulatory Affairs Worldwide


Mary F. Johnson, PhD

Executive Vice President, Biostatistics

 

Francois Xavier Lacasse, PhD

Director, Drug Development, Scientific and Regulatory Affairs, Anapharm

 

Stephane Lamouche, MSc, PhD

Project Manager, Drug Development, Scientific and Regulatory Affairs, Anapharm

 

Patricia Milani

Senior Director, Quality Assurance, Anapharm

 

Thomas Noto

Executive Director, Document Management and Publishing

 

Mike Ryan

Executive Director, Strategic Partnering Services

 

Peggy Schrammel

Vice President, Clinical Research, Phase IV Development

 

Frank Schurer

Senior Director, Global Safety and Pharmacovigilance


Philippa Smit-Marshall, MD

Vice President, Medical Affairs, Europe and Asia Pacific

 

Mario Tanguay, BPharm, PhD

Vice President, Scientific and Regulatory Affairs, Anapharm

 

Fethi Trabelsi, PhD

Director, Scientific and Regulatory Affairs, Anapharm


Marty Valania

Vice President, Corporate Quality Assurance and Compliance

 

Jan Willem van der Velden, MD, FFPM

Senior Vice President, Global Safety and Pharmacovigilance


Duu-Gong Wu, PhD

Executive Director, PharmaNet Consulting

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390